Citation: J. Bernhard et al., Response shift in the perception of health for utility evaluation: an explorative investigation, EUR J CANC, 37(14), 2001, pp. 1729-1735
Authors:
Morgenegg, S
Maibach, R
Chaperon, DN
Herzog, K
Altwegg, M
Citation: S. Morgenegg et al., Antibodies against recombinant heat shock protein 65 of Tropheryma whipplei in patients with and without Whipple's disease, J MICROB M, 47(3), 2001, pp. 299-306
Authors:
Roth, AD
Maibach, R
Martinelli, G
Fazio, N
Aapro, MS
Pagani, O
Morant, R
Borner, MM
Herrmann, R
Honegger, H
Cavalli, F
Alberto, P
Castiglione, M
Goldhirsch, A
Citation: Ad. Roth et al., Docetaxel (Taxotere (R))-cisplatin (TC): An effective drug combination in gastric carcinoma, ANN ONCOL, 11(3), 2000, pp. 301-306
Authors:
Morant, R
Bernhard, J
Maibach, R
Borner, M
Fey, MF
Thurlimann, B
Jacky, E
Trinkler, F
Bauer, J
Zulian, G
Hanselmann, S
Hurny, C
Hering, F
Citation: R. Morant et al., Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma, ANN ONCOL, 11(2), 2000, pp. 183-188
Authors:
Zoppi, M
Braunschweig, S
Kuenzi, UP
Maibach, R
Hoigne, R
Citation: M. Zoppi et al., Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne/St.Gallen, EUR J CL PH, 56(5), 2000, pp. 427-430
Authors:
Bernhard, J
Hurny, C
Maibach, R
Herrmann, R
Laffer, U
Citation: J. Bernhard et al., Quality of life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvantchemotherapy, ANN ONCOL, 10(7), 1999, pp. 775-782
Citation: Hp. Schmid et al., Prostate-specific antigen doubling time: A potential surrogate end point in hormone-refractory prostate cancer, J CL ONCOL, 17(5), 1999, pp. 1645-1646